522 related articles for article (PubMed ID: 15990995)
41. Sequence comparison of putative regulatory DNA of the 5' flanking region of the myeloperoxidase gene in normal and leukemic bone marrow cells.
Austin GE; Lam L; Zaki SR; Chan WC; Hodge T; Hou J; Swan D; Zhang W; Racine M; Whitsett C
Leukemia; 1993 Sep; 7(9):1445-50. PubMed ID: 8396697
[TBL] [Abstract][Full Text] [Related]
42. Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis.
Soupir CP; Vergilio JA; Dal Cin P; Muzikansky A; Kantarjian H; Jones D; Hasserjian RP
Am J Clin Pathol; 2007 Apr; 127(4):642-50. PubMed ID: 17369142
[TBL] [Abstract][Full Text] [Related]
43. CD117/CD34 expression in leukemic blasts.
Wells SJ; Bray RA; Stempora LL; Farhi DC
Am J Clin Pathol; 1996 Aug; 106(2):192-5. PubMed ID: 8712172
[TBL] [Abstract][Full Text] [Related]
44. PRAME mRNA levels in cases with chronic leukemia: Clinical importance and review of the literature.
Paydas S; Tanriverdi K; Yavuz S; Seydaoglu G
Leuk Res; 2007 Mar; 31(3):365-9. PubMed ID: 16914202
[TBL] [Abstract][Full Text] [Related]
45. PRAME mRNA levels in cases with acute leukemia: clinical importance and future prospects.
Paydas S; Tanriverdi K; Yavuz S; Disel U; Baslamisli F; Burgut R
Am J Hematol; 2005 Aug; 79(4):257-61. PubMed ID: 16044453
[TBL] [Abstract][Full Text] [Related]
46. Epigenetic heterochromatin markers distinguish terminally differentiated leukocytes from incompletely differentiated leukemia cells in human blood.
Popova EY; Claxton DF; Lukasova E; Bird PI; Grigoryev SA
Exp Hematol; 2006 Apr; 34(4):453-62. PubMed ID: 16569592
[TBL] [Abstract][Full Text] [Related]
47. Cell growth in chronic myeloid leukemia at blast crisis.
Papaphilis AD
Anticancer Res; 1990; 10(6):1677-81. PubMed ID: 2285242
[TBL] [Abstract][Full Text] [Related]
48. Expression of nucleolar antigen p145 in bone marrow cells of patients with myeloid leukemias.
Raza A; Imren S; Gezer S; Verkh L; Freeman JW
Cancer Res; 1989 Jan; 49(2):482-7. PubMed ID: 2910466
[TBL] [Abstract][Full Text] [Related]
49. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.
Pattengale PK; Sundstrom C; Yu AL; Levine A
Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341
[TBL] [Abstract][Full Text] [Related]
50. Acute bilineage leukemia after chronic myelogenous leukemia.
Williams SR; Wellhausen SR; Barker RL; Janckila AJ
J Ky Med Assoc; 1997 Sep; 95(9):393-6. PubMed ID: 9322413
[TBL] [Abstract][Full Text] [Related]
51. Discordant expression of myeloid antigens and myeloperoxidase in a case of t(8;21) positive AML expressing CD7.
Hirai K; Torimoto Y; Moriichi K; Sato K; Ohnishi K; Taya N; Kohgo Y
Int J Hematol; 1999 Jul; 70(1):30-5. PubMed ID: 10446492
[TBL] [Abstract][Full Text] [Related]
52. Repeated blast crisis (BC) of changing morphology, immunologic phenotype and cytogenetics in chronic myeloid leukemia (CML).
Jehn U; Mittermüller J; Greither L; Clemm C; Heinemann V; Lorenz T; Gross HJ
Anticancer Res; 1989; 9(6):1721-3. PubMed ID: 2627124
[TBL] [Abstract][Full Text] [Related]
53. [Certain biochemical features of leukocytes in blast crisis of chronic myelogenous leukemia].
Kharchenko MF; Rybakova LP; Filanovskaia LI; Saltykova LB; Bitiukova ES; Shcherbakova EG; Rukavitsyn OA; Bessmel'tsev SS; Abdulkadyrov KM; Blinov MM
Vopr Med Khim; 1998; 44(3):274-80. PubMed ID: 9703628
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of peroxidase activity by alpha-naphthol/pyronine staining compared with benzidine staining in 101 acute leukemia cases.
Latger-Cannard V; Bardet V; Malet M; Lagrange M; Empereur F; Fenneteau O
Lab Hematol; 2010 Dec; 16(4):76-82. PubMed ID: 21097443
[TBL] [Abstract][Full Text] [Related]
55. Myeloperoxidase mRNA detection for lineage determination of leukemic blasts: retrospective analysis.
Crisan D; Anstett MJ
Leukemia; 1995 Jul; 9(7):1264-75. PubMed ID: 7630202
[TBL] [Abstract][Full Text] [Related]
56. A novel quantitative 'stretch PCR assay', that detects a dramatic increase in telomerase activity during the progression of myeloid leukemias.
Tatematsu K; Nakayama J; Danbara M; Shionoya S; Sato H; Omine M; Ishikawa F
Oncogene; 1996 Nov; 13(10):2265-74. PubMed ID: 8950994
[TBL] [Abstract][Full Text] [Related]
57. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
[TBL] [Abstract][Full Text] [Related]
58. Immunophenotypic characteristics of the blast crisis in chronic myeloid leukemia.
López-Karpovitch X; Cárdenas R; Piedras J
Rev Invest Clin; 1997; 49(1):31-6. PubMed ID: 9229753
[TBL] [Abstract][Full Text] [Related]
59. "Acute myelogenous leukemia like" translocations in CML blast crisis: two new cases of inv(16)/t(16;16) and a review of the literature.
Patel BB; Mohamed AN; Schiffer CA
Leuk Res; 2006 Feb; 30(2):225-32. PubMed ID: 16076492
[TBL] [Abstract][Full Text] [Related]
60. Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis.
Shumak KH; Baker MA; Taub RN; Coleman MS
Cancer Res; 1980 Nov; 40(11):4048-52. PubMed ID: 6937237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
